Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001307632-14-000008
Filing Date
2014-12-11
Accepted
2014-12-11 19:01:06
Documents
1
Period of Report
2014-12-10

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgardoc.html 4  
1 PRIMARY DOCUMENT edgardoc.xml 4 4262
  Complete submission text file 0001307632-14-000008.txt   5639
Mailing Address 950 TOWER LANE SUITE 900 FOSTER CITY CA 94404-2125
Business Address 950 TOWER LANE SUITE 900 FOSTER CITY CA 94404-2125 650-358-3456
SCICLONE PHARMACEUTICALS INC (Issuer) CIK: 0000880771 (see all company filings)

EIN.: 943116852 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 950 TOWER LANE, SUITE 900 FOSTER CITY CA 94404-2125
Business Address
Hawkins Richard J (Reporting) CIK: 0001307632 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-19825 | Film No.: 141281876